Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xe-129 and 19F MRI in Cystic Fibrosis and Asthma
NCT02740868Phase 2Recruiting
- Sponsor
- SickKids
- Start
- Aug 2015
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas, perflutren in cystic fibrosis (CF), asthma, sponsored by SickKids. Started Aug 2015; status: recruiting.
02
Drugs
hyperpolarized xenon gasperflutren
03
Conditions
cystic fibrosis (CF)asthma
Beyond the preview
Go deeper on NCT02740868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740868.